中国肺癌杂志
中國肺癌雜誌
중국폐암잡지
CHINESE JOURNAL OF LUNG CANCER
2001年
3期
175-177
,共3页
杨俊兰%戴为民%石廷章%魏秀芳
楊俊蘭%戴為民%石廷章%魏秀芳
양준란%대위민%석정장%위수방
MDR1 MRP LRP RT-PCR 非小细胞肺癌
MDR1 MRP LRP RT-PCR 非小細胞肺癌
MDR1 MRP LRP RT-PCR 비소세포폐암
目的 观察肺癌组织及癌旁肺组织MDR1-mRNA、MRP-mRNA及LRP-mRNA的表达。方法 采用RT-PCR法检测30例肺癌患者癌组织和正常肺组织中MDR1-mRNA、MRP-mRNA和LRP-mRNA的表达情况。结果 MDR1-mRNA在肺癌组织及癌旁肺组织的表达阳性率分别为40%及16.67%(P=0.045),其表达与细胞分化程度、临床分期及病理类型无明显关系。MRP-mRNA在肺癌组织及癌旁肺组织的表达分别为43.33%及26.67%,低分化者MRP的表达率明显高于中高分化者(P=0.03),其表达与临床分期无明显关系。LRP-mRNA在肺癌组织及癌旁肺组织的表达分别为56.67%及10%(P=0.000?4),其表达与肿瘤类型、临床分期及癌细胞的分化程度无明显关系。30例肺癌组织中MDR1-mRNA、MRP-mRNA、LRP-mRNA共同表达者7例(23.33%),三者均无表达者10例(33.33%),三者的一致性达56.67%。结论 MDR1-mRNA、MRP-mRNA、LRP-mRNA在肺癌的耐药中可能起重要作用。
目的 觀察肺癌組織及癌徬肺組織MDR1-mRNA、MRP-mRNA及LRP-mRNA的錶達。方法 採用RT-PCR法檢測30例肺癌患者癌組織和正常肺組織中MDR1-mRNA、MRP-mRNA和LRP-mRNA的錶達情況。結果 MDR1-mRNA在肺癌組織及癌徬肺組織的錶達暘性率分彆為40%及16.67%(P=0.045),其錶達與細胞分化程度、臨床分期及病理類型無明顯關繫。MRP-mRNA在肺癌組織及癌徬肺組織的錶達分彆為43.33%及26.67%,低分化者MRP的錶達率明顯高于中高分化者(P=0.03),其錶達與臨床分期無明顯關繫。LRP-mRNA在肺癌組織及癌徬肺組織的錶達分彆為56.67%及10%(P=0.000?4),其錶達與腫瘤類型、臨床分期及癌細胞的分化程度無明顯關繫。30例肺癌組織中MDR1-mRNA、MRP-mRNA、LRP-mRNA共同錶達者7例(23.33%),三者均無錶達者10例(33.33%),三者的一緻性達56.67%。結論 MDR1-mRNA、MRP-mRNA、LRP-mRNA在肺癌的耐藥中可能起重要作用。
목적 관찰폐암조직급암방폐조직MDR1-mRNA、MRP-mRNA급LRP-mRNA적표체。방법 채용RT-PCR법검측30례폐암환자암조직화정상폐조직중MDR1-mRNA、MRP-mRNA화LRP-mRNA적표체정황。결과 MDR1-mRNA재폐암조직급암방폐조직적표체양성솔분별위40%급16.67%(P=0.045),기표체여세포분화정도、림상분기급병리류형무명현관계。MRP-mRNA재폐암조직급암방폐조직적표체분별위43.33%급26.67%,저분화자MRP적표체솔명현고우중고분화자(P=0.03),기표체여림상분기무명현관계。LRP-mRNA재폐암조직급암방폐조직적표체분별위56.67%급10%(P=0.000?4),기표체여종류류형、림상분기급암세포적분화정도무명현관계。30례폐암조직중MDR1-mRNA、MRP-mRNA、LRP-mRNA공동표체자7례(23.33%),삼자균무표체자10례(33.33%),삼자적일치성체56.67%。결론 MDR1-mRNA、MRP-mRNA、LRP-mRNA재폐암적내약중가능기중요작용。
Objective To investigate the expression of multidrug resistance (MDR1), multidrug resistance-associated protein (MRP) and lung resistance protein (LRP) genes in patients with non-small cell lung cancer (NSCLC). Methods Expression of MDR1, MRP and LRP genes was detected in 30 NSCLC patients by RT-PCR method. Results The positive rates of MDR1 expression were 40% and 16.67% respectively in lung cancer tissues and normal lung tissues (P=0.045), and it was not associated with the degree of cell differentiation, histological classification and the clinical stage. The positive rates of MRP expression were 43.33% and 26.67% respectively in lung cancer tissues and normal lung tissues. Its expression was related to degree of cell differentiation (P=0.03), but not to the histological classification and the clinical stage. LRP expression of lung cancer tissues (56.67%) was much higher than that of normal tissues (P=0.000?4), and it was not associated with degree of cell differentiation, histological classification and the clinical stage. Of the 30 lung cancer specimens, 7 expressed all the three kinds of genes, and 10 expressed none of them. The coincident rate was 56.67%. Conclusion The results suggest that MDR1, MRP and LRP gene may play important roles in drug resistance in NSCLC.